Bone metabolism after bariatric surgery

Journal of Bone and Mineral Research

Volumn 29, Issue 7, 2014, Pages 1507-1518

  Yu, Elaine W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BARIATRIC SURGERY; BIOCHEMICAL MARKERS OF BONE TURNOVER; DXA; OBESITY

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE;

ADJUSTABLE GASTRIC BANDING; BARIATRIC SURGERY; BODY COMPOSITION; BODY FAT; BODY MASS; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE STRENGTH; BONE TURNOVER; CALCIUM METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; ENERGY EXPENDITURE; FEMUR NECK; GASTRIC BANDING; HIP; HUMAN; HUMERUS FRACTURE; LEG FRACTURE; LUMBAR SPINE; MEASUREMENT ERROR; METABOLIC ACIDOSIS; MORPHOMETRICS; NONHUMAN; OBESITY; OSTEITIS FIBROSA; OSTEOLYSIS; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREMENOPAUSE; QUANTITATIVE ANALYSIS; RADIUS; REVIEW; ROUX EN Y GASTRIC BYPASS; SECONDARY HYPERPARATHYROIDISM; SLEEVE GASTRECTOMY; STOMACH BYPASS; SYSTEMATIC REVIEW; TIBIA; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ANIMAL; ANIMAL MODEL; BONE; DIAGNOSTIC IMAGING; FRACTURES, BONE; METABOLISM; PATHOLOGY;

ANIMALS; BARIATRIC SURGERY; BONE AND BONES; BONE RESORPTION; DIAGNOSTIC IMAGING; FRACTURES, BONE; HUMANS; MODELS, ANIMAL;

EID: 84903272115     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2226     Document Type: Review

References (135)

1. Chang S-H, Stoll CRT, Song J, Varela JE, Eagon CJ, Colditz GA., The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014; 149 (3): 275-87.
2. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery,long-term cardiovascular events. JAMA. 2012; 307 (1): 56-65.
3. Fryar CD, Carroll MD, Ogden CL., Prevalence of overweight, obesity, and extreme obesity among adults: United States, trends 1960-1962 through 2009-2010. Hyattsville, MD: National Center for Health Statistics; 2012. Available from: http://www.cdc.gov/nchs/data/hestat/obesity-adult-09-10/obesity-adult-09-10.pdf.
4. Flegal KM, Carroll MD, Kit BK, Ogden CL., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012; 307 (5): 483-90.
5. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss,glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013; 309 (21): 2250-61.
6. Buchwald H, Oien DM., Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013; 23 (4): 427-36.
7. Mellstrom D, Rundgren A., Long-term effects after partial gastrectomy in elderly men. A longitudinal population study of men between 70 and 75 years of age. Scand J Gastroenterol. 1982; 17 (3): 433-9.
8. Zittel TT, Zeeb B, Maier GW, et al. High prevalence of bone disorders after gastrectomy. Am J Surg. 1997; 174 (4): 431-8.
9. Melton LJ 3rd, Crowson CS, Khosla S, O'Fallon WM., Fracture risk after surgery for peptic ulcer disease: a population-based cohort study. Bone. 1999; 25 (1): 61-7.
10. Maier GW, Kreis ME, Zittel TT, Becker HD., Calcium regulation and bone mass loss after total gastrectomy in pigs. Ann Surg. 1997; 225 (2): 181-92.
11. Krolner B, Ranlov PJ, Clemmesen T, Nielsen SP., Bone loss after gastroplasty for morbid obesity: side-effect or adaptive response to weight reduction ? Lancet. 1982; 1 (8278): 956-7.
12. Tsiftsis DDA, Mylonas P, Mead N, Kalfarentzos F, Alexandrides TK., Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. a physiological adaptation to weight loss ? Obes Surg. 2009; 19 (11): 1497-503.
13. Parfitt AM, Miller MJ, Frame B, et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med. 1978; 89 (2): 193-9.
14. Parfitt AM, Podenphant J, Villanueva AR, Frame B., Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone. 1985; 6 (4): 211-20.
15. Compston JE, Vedi S, Gianetta E, Watson G, Civalleri D, Scopinaro N., Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology. 1984; 87 (2): 350-6.
16. Marceau P., Does bone change after biliopancreatic diversion ? J Gastrointest Surg. 2002; 6 (5): 690-8.
17. Carlin AM, Rao DS, Yager KM, Parikh NJ, Kapke A., Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009; 5 (4): 444-9.
18. Vilarrasa N, San José P, García I, et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg. 2011; 21 (4): 465-72.
19. von Mach M-A, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U., Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism. 2004; 53 (7): 918-21.
20. Yu EW, Bouxsein M, Roy AE, et al. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res. 2014; 29 (3): 542-50.
21. Dixon JB, Strauss BJG, Laurie C, O'Brien PE., Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity. 2007; 15 (5): 1187-98.
22. Olbers T, Björkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty. Ann Surg. 2006; 244 (5): 715-22.
23. Nogues X, Goday A, Peña MJ, et al. [Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass]. Cirugía Española. 2010; 88 (2): 103-9.
24. Goode LR, Brolin RE, Chowdhury HA, Shapses SA., Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004; 12 (1): 40-7.
25. Pereira FA, de Castro JA, dos Santos JE, Foss MC, Paula FJ., Impact of marked weight loss induced by bariatric surgery on bone mineral density and remodeling. Braz J Med Biol Res. 2007; 40 (4): 509-17.
26. Stein EM, Carrelli A, Young P, Bucovsky M, Zhang C, Schrope B, et al. Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab. 2013; 98 (2): 541-9.
27. Yu EW, Putman M, Bouxsein M, Roy A, Derrico N, Finkelstein J., Endosteal resorption and worsening cortical porosity after Roux-en-Y gastric bypass surgery. American Society for Bone and Mineral Research Conference; October 2013; Baltimore, MD.
28. Pories WJ., Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008; 93(11 Suppl 1): S89-96.
29. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review, meta-analysis. JAMA. 2004; 292 (14): 1724-37.
30. Crowley LV, Seay J, Mullin G., Late effects of gastric bypass for obesity. Am J Gastroenterol. 1984; 79 (11): 850-60.
31. Al-Shoha A, Qiu S, Palnitkar S, Rao DS., Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. Endocr Pract. 2009; 15 (6): 528-33.
32. Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling JW., Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int. 1991; 1 (3): 177-81.
33. Casagrande DS, Repetto G, Mottin CC, et al. Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg. 2012; 22 (8): 1287-92.
34. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab. 2008; 93 (10): 3735-40.
35. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL., Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004; 89 (3): 1061-5.
36. Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab. 2010; 95 (1): 159-66.
37. Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA., True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2006; 14 (11): 1940-8.
38. Riedl M, Vila G, Maier C, et al. Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab. 2008; 93 (6): 2307-12.
39. Mahdy T, Atia S, Farid M, Adulatif A., Effect of Roux-en-Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008; 18 (12): 1526-31.
40. El-Kadre LJ, Rocha PRS, de Almeida Tinoco AC, Tinoco RC., Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2004; 14 (8): 1062-6.
41. DiGiorgi M, Daud A, Inabnet WB, et al. Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg. 2008; 18 (9): 1144-8.
42. Biagioni MF, Mendes AL, Nogueira CR, Paiva SA, Leite CV, Mazeto GM., Weight-reducing gastroplasty with Roux-en-Y gastric bypass: impact on vitamin D status and bone remodeling markers. Metab Syndr Relat Disord. 2014; 12 (1): 11-5.
43. Sinha N, Shieh A, Stein EM, et al. Increased PTH and 1.25(OH)2D levels associated with increased markers of bone turnover following bariatric surgery. Obesity. 2011; 19 (12): 2388-93.
44. Granado-Lorencio F, Simal-Antón A, Salazar-Mosteiro et al. Time-course changes in bone turnover markers and fat-soluble vitamins after obesity surgery. Obes Surg. 2010; 20 (11): 1524-9.
45. Johnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW., Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005; 9 (8): 1106-10; discussion 10-1.
46. Vilarrasa N, Gómez JM, Elio I, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg. 2009; 19 (7): 860-6.
47. Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2009; 19 (1): 41-6.
48. Kaulfers A-MD, Bean JA, Inge TH, Dolan LM, Kalkwarf HJ., Bone loss in adolescents after bariatric surgery. Pediatrics. 2011; 127 (4): e956-61.
49. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357 (8): 741-52.
50. Giusti V, Gasteyger C, Suter M, Heraief E, Gaillard RC, Burckhardt P., Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up. Int J Obes Relat Metab Disord. 2005; 29 (12): 1429-35.
51. Pugnale N, Giusti V, Suter M, et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord. 2003; 27 (1): 110-6.
52. Di Renzo L, Carbonelli MG, Bianchi A, et al. Body composition changes after laparoscopic adjustable gastric banding: what is the role of -174G > C interleukin-6 promoter gene polymorphism in the therapeutic strategy ? Int J Obes Relat Metab Disord. 2011; 36 (3): 369-78.
53. Strauss BJG, Marks SJ, Growcott JP, et al. Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetologica. 2003; 40 (S1): s266-9.
54. Nadler EP, Reddy S, Isenalumhe A, et al. Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status. J Am Coll Surg. 2009; 209 (5): 638-44.
55. Cundy T, Evans MC, Kay RG, Dowman M, Wattie D, Reid IR., Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients. Br J Surg. 1996; 83 (10): 1468-72.
56. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T., Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg. 2003; 13 (3): 383-8.
57. Li JF, Lai DD, Ni B, Sun KX., Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg. 2013; 56 (6): E158-64.
58. Pluskiewicz W, Bužga M, Holéczy P, Bortlík L, Šmajstrla V, Adamczyk P., Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study. Obes Surg. 2012; 22 (7): 1068-76.
59. Ruiz-Tovar J, Oller I, Priego P, et al. Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy. Obes Surg. 2013; 1-6.
60. Vilarrasa N, Gordejuela AGR, Gómez-Vaquero C, et al. Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes Surg. 2013; 23 (12): 2086-91.
61. Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C, et al. Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology. 2013; 154 (6): 2015-24.
62. Tsai WS, Inge TH, Burd RS., Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med. 2007; 161 (3): 217-21.
63. Schilling PL, Davis MM, Albanese CT, Dutta S, Morton J., National trends in adolescent bariatric surgical procedures and implications for surgical centers of excellence. J Am Coll Surg. 2008; 206 (1): 1-12.
64. Zwintscher NP, Azarow KS, Horton JD, Newton CR, Martin MJ., The increasing incidence of adolescent bariatric surgery. J Pediatr Surg. 2013; 48 (12): 2401-7.
65. Consortium LABS, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009; 361 (5): 445-54.
66. Papapietro K, Massardo T, Riffo A, et al. [Bone mineral density disminution post Roux-Y bypass surgery]. Nutr Hosp. 2013; 28 (3): 631-6.
67. Balsa JA, Botella-Carretero JI, Peromingo R, et al. Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density. Obes Surg. 2010; 20 (4): 468-73.
68. Rothney MP, Brychta RJ, Schaefer EV, Chen KY, Skarulis MC., Body composition measured by dual-energy X-ray absorptiometry half-body scans in obese adults. Obesity (Silver Spring). 2009; 17 (6): 1281-6.
69. Bolotin HH., DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone. 2007; 41 (1): 138-54.
70. Yu EW, Thomas BJ, Brown JK, Finkelstein JS., Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res. 2012; 27 (1): 119-2.
71. Binkley N, Krueger D, Vallarta-Ast N., An overlying fat panniculus affects femur bone mass measurement. J Clin Densitom. 2003; 6 (3): 199-204.
72. Evans EM, Mojtahedi MC, Kessinger RB, Misic MM., Simulated change in body fatness affects Hologic QDR 4500A whole body and central DXA bone measures. J Clin Densitom. 2006; 9 (3): 315-22.
73. Tothill P, Laskey MA, Orphanidou CI, van Wijk M., Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol. 1999; 72 (859): 661-9.
74. Svendsen OL, Haarbo J, Hassager C, Christiansen C., Accuracy of measurements of body composition by dual-energy X-ray absorptiometry in vivo. Am J Clin Nutr. 1993; 57 (5): 605-8.
75. Knapp KM, Welsman JR, Hopkins SJ, Fogelman I, Blake GM., Obesity increases precision errors in dual-energy X-ray absorptiometry measurements. J Clin Densitom. 2012; 15 (3): 315-9.
76. Blake GM, Parker JC, Buxton FM, Fogelman I., Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans. Br J Radiol. 1993; 66 (790): 902-6.
77. Levitt DG, Beckman LM, Mager JR, Valentine B, Sibley SD, Beckman TR, et al. Comparison of DXA and water measurements of body fat following gastric bypass surgery and a physiological model of body water, fat, and muscle composition. J Appl Physiol. 2010; 109 (3): 786-95.
78. Sowers MR, Zheng H, Greendale GA, et al. Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab. 2013; 98 (7): 2854-63.
79. Smith SM, Wastney ME, O'Brien KO, et al. Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the mir space station. J Bone Miner Res. 2005; 20 (2): 208-18.
80. Ashrafian H, Bueter M, Ahmed K, et al. Metabolic surgery: an evolution through bariatric animal models. Obes Rev. 2010; 11 (12): 907-20.
81. Rao RS, Rao V, Kini S., Animal models in bariatric surgery-a review of the surgical techniques and postsurgical physiology. Obes Surg. 2010; 20 (9): 1293-305.
82. Odaibo SK, Lee KY, Chey WY., Motility abnormality in dogs with gastrojejunostomy. Scand J Gastroenterol Suppl. 1986; 124: 203-7.
83. Nocca D, Gagner M, Abente FC, et al. Laparoscopic gastric bypass with silicone band in a pig model: prevention of anastomotic dilatation - feasibility study. Obes Surg. 2005; 15 (4): 523-7.
84. Xu Y, Ohinata K, Meguid MM, et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res. 2002; 107 (1): 56-63.
85. Meguid MM, Ramos EJ, Suzuki S, et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg. 2004; 8 (5): 621-30.
86. Monteiro MP, Monteiro JD, Aguas AP, Cardoso MH., A rat model of restrictive bariatric surgery with gastric banding. Obes Surg. 2006; 16 (1): 48-51.
87. Wang Y, Liu J., Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg. 2009; 19 (3): 357-62.
88. Lopez PP, Nicholson SE, Burkhardt GE, Johnson RA, Johnson FK., Development of a sleeve gastrectomy weight loss model in obese Zucker rats. J Surg Res. 2009; 157 (2): 243-50.
89. Wang Y, Liu J., Sleeve gastrectomy relieves steatohepatitis in high-fat-diet-induced obese rats. Obes Surg. 2009; 19 (7): 921-5.
90. Pereferrer FS, Gonzalez MH, Rovira AF, Blasco SB, Rivas AM, del Castillo Dejardin D., Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg. 2008; 18 (1): 97-108.
91. Liu W, Zassoko R, Mele T, et al. Establishment of duodenojejunal bypass surgery in mice: a model designed for diabetic research. Microsurgery. 2008; 28 (3): 197-202.
92. Yin DP, Gao Q, Ma LL, et al. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice. Ann Surg. 2011; 254 (1): 73-82.
93. Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab. 2012; 97 (6): E1023-31.
94. Stenstrom B, Furnes M, Tommeras K, Syversen U, Zhao C, Chen D., Mechanism of gastric bypass-induced body weight loss: one-year follow-up after micro-gastric bypass in rats. J Gastrointest Surg. 2006; 10 (10): 1384-91.
95. Pérez-Castrillón JL, Riancho JA, Luis D, et al. The deleterious effect of bariatric surgery on cortical and trabecular bone density in the femurs of non-obese, type 2 diabetic Goto-Kakizaki rats. Obes Surg. 2012; 22 (11): 1755-60.
96. Abegg K, Gehring N, Wagner CA, et al. Roux-en-Y gastric bypass surgery reduces bone mineral density and induces metabolic acidosis in rats. Am J Physiol Regul Integr Comp Physiol. 2013; 305 (9): R999- R1099.
97. De Prisco C, Levine SN., Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005; 329 (2): 57-61.
98. Goldner WS, O'Dorisio TM, Dillon JS, Mason EE., Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002; 12 (5): 685-92.
99. Benhalima K, Mertens A, Van den Bruel A, et al. A brown tumor after biliopancreatic diversion for severe obesity. Endocr J. 2009; 56 (2): 263-8.
100. Moreiro J, Ruiz O, Perez G, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg. 2007; 17 (3): 348-54.
101. Alcalde OL, Duce AM, Bustos FA, et al. Ultrasonic value is not useful to detect bone changes following a biliopancreatic diversion. Obes Surg. 2010; 21 (2): 173-8.
102. Valderas J, Velasco S, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg. 2009; 19 (8): 1132-8.
103. Holbrook TL, Barrett-Connor E., The association of lifetime weight and weight control patterns with bone mineral density in an adult community. Bone Miner. 1993; 20 (2): 141-9.
104. Duran de Campos C, Dalcanale L, Pajecki D, Garrido AB, Halpern A., Calcium intake and metabolic bone disease after eight years of Roux-en-Y gastric bypass. Obes Surg. 2008; 18 (4): 386-90.
105. Ott M, Fanti P, Malluche H, et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg. 1992; 2 (4): 341-8.
106. Bano G, Rodin DA, Pazianas M, Nussey SS., Reduced bone mineral density after surgical treatment for obesity. Int J Obes Relat Metab Disord. 1999; 23 (4): 361-5.
107. Lalmohamed A, De Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based,retrospective cohort study. BMJ. 2012; 345: e5085.
108. Nakamura KM, Haglind EGC, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporosis Int. 2014; 25 (1): 151-8.
109. Nielson CM, Marshall LM, Adams AL, et al. BMI and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res. 2011; 26 (3): 496-502.
110. Compston JE, Watts NB, Chapurlat R, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med. 2011; 124 (11): 1043-50.
111. Prieto-Alhambra D, Premaor MO, Fina Avilés F, et al. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res. 2012; 27 (2): 294-300.
112. Johansson H, Kanis JA, Oden A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014; 29 (1): 223-33.
113. Premaor MO, Compston JE, Fina Avilés F, et al. The association between fracture site and obesity in men: a population-based cohort study. J Bone Miner Res. 2013; 28 (8): 1771-7.
114. Himes CL, Reynolds SL., Effect of obesity on falls, injury, and disability. J Am Geriatr Soc. 2011; 60 (1): 124-9.
115. Berarducci A, Haines K, Murr MM., Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res. 2009; 22 (1): 35-41.
116. Premaor MO, Pilbrow L, Tonkin C, Parker R, Compston J., Obesity and fractures in postmenopausal women. J Bone Miner Res. 2010; 25 (2): 292-7.
117. Premaor M, Parker RA, Cummings S, et al. Predictive value of FRAX for fracture in obese older women. J Bone Miner Res. 2012; 28 (1): 188-95.
118. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013; 19 (2): 337-72.
119. Williams SE., Metabolic bone disease in the bariatric surgery patient. J Obes. 2011; 2011: 1-9.
120. Heber D, Greenway F, Kaplan L, Livingston E, Salvador J, Still C., Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010; 95 (11): 4823.
121. Flores L, Martínez Osaba MJ, Andreu A, Moizé V, Rodriguez L, Vidal J., Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg. 2010; 20 (6): 738-7343.
122. McClung MR, Boonen S, Torring O, et al. Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis. J Bone Miner Res. 2012; 27 (1): 211-8.
123. McCloskey EV, Johansson H, Oden A, et al. Ten-year fracture probability identifies women who will benefit from clodronate therapy - additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int. 2009; 20 (5): 811-7.
124. Eastell R, Black DM, Boonen S, et al. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab. 2009; 94 (9): 3215-25.
125. Rosen CJ, Brown S., Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med. 2003; 348 (15): 1503-4.
126. Slater G., Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004; 8 (1): 48-55.
127. Quercia I, Dutia R, Kotler DP, Belsley S, Laferrere B., Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014; 40 (2): 87-94.
128. Ballantyne GH, Gumbs A, Modlin IM., Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005; 15 (5): 692-9.
129. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B., Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006; 91 (4): 1578-81.
130. Wong IP, Baldock PA, Herzog H., Gastrointestinal peptides and bone health. Curr Opin Endocrinol Diabetes Obes. 2010; 17 (1): 44-50.
131. Wucher H, Ciangura C, Poitou C, Czernichow S., Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers. Obes Surg. 2008; 18 (1): 58-65.
132. Stylopoulos N, Hoppin AG, Kaplan LM., Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity. 2009; 17 (10): 1839-47.
133. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G., Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes Relat Metab Disord. 2012; 36 (11): 1373-9.
134. Brzozowska MM, Sainsbury A, Eisman JA, Baldock PA, Center JR., Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev. 2013; 14 (1): 52-6.
135. Hage MP, El-Hajj Fuleihan G., Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass. Osteoporos Int. 2013; 1-17.